1 / 12

Therapeutic Drug Monitoring Market Projected to Reach 2.55 Billion USD by 2020

On the basis of technology, the therapeutic drug monitoring market is categorized into three segments namely, immunoassays, proteomic technologies and others. The immunoassays segment is expected to account for the largest share of its technology market in 2015.

mmmwaterman
Télécharger la présentation

Therapeutic Drug Monitoring Market Projected to Reach 2.55 Billion USD by 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MarketsandMarkets Presents Therapeutic Drug Monitoring Market worth 2.55 Billion USD by 2020 http://www.marketsandmarkets.com/Market-Reports/therapeutic-drug-monitoring-market-155350443.html

  2. The report "Therapeutic Drug Monitoring Market by Product (Consumables, Equipment), Technology (Immunoassays, Proteomic Technologies), Class of Drug (Antiepileptics, Antibiotics, Immunosuppressants), End User (Hospital Labs, Private Labs) - Global Forecast to 2020", The therapeutic drug monitoring market is projected to reach USD 2.55 Billion by 2020 from USD 1.78 Billion in 2015, growing at a CAGR of 7.4% during the forecast period (2015–2020). Browse 80 tables and 55 figures spread through 142 Pagess and in-depth TOC on "Therapeutic Drug Monitoring Market by Product (Consumables, Equipment), Technology (Immunoassays, Proteomic Technologies), Class of Drug (Antiepileptics, Antibiotics, Immunosuppressants), End User (Hospital Labs, Private Labs) - Global Forecast to 2020" http://www.marketsandmarkets.com/Market-Reports/therapeutic-drug-monitoring-market-155350443.html http://www.marketsandmarkets.com/Market-Reports/therapeutic-drug-monitoring-market-155350443.html

  3. Early buyers will receive 10% customization on this report. http://www.marketsandmarkets.com/Market-Reports/therapeutic-drug-monitoring-market-155350443.html

  4. Therapeutic Drug Monitoring Market provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the therapeutic drug monitoring market along with the estimates and forecasts of the revenue. http://www.marketsandmarkets.com/Market-Reports/therapeutic-drug-monitoring-market-155350443.html

  5. The technological advances in tests used to monitor therapeutic drugs, increased knowledge of pharmacogenetics and pharmacokinetics of drugs, need for better healthcare in developing countries, and rising prevalence of psychiatric diseases and cancer are the major drivers for the therapeutic drug monitoring market. Adjunct technologies such as biomarker identification using proteomics to accurately identify clinical outcomes and genetic testing are expected to benefit the growth of the therapeutic drug monitoring market. However, high infrastructure costs and dearth of skilled resources may restrain the market growth. http://www.marketsandmarkets.com/Market-Reports/therapeutic-drug-monitoring-market-155350443.html

  6. In this report, the therapeutic drug monitoring market is broadly segmented by product, technology, class of drug, end user, and region. On the basis of product, the therapeutic drug monitoring market is divided into consumables and equipment. The equipment segment is further segmented into immunoassay analyzers, proteomic equipment, and other equipment. http://www.marketsandmarkets.com/Market-Reports/therapeutic-drug-monitoring-market-155350443.html

  7. On the basis of technology, the therapeutic drug monitoring market is categorized into three segments namely, immunoassays, proteomic technologies, and others. The immunoassays segment is classified into chemiluminescent assay (CLIA), cloned enzyme donor immunoassay (CEDIA), fluorescence polarization immunoassay (FPIA), particle-enhanced turbidimetric inhibition immunoassay (PETINIA), and others. The proteomic technologies segment is further split into liquid chromatography/mass spectrometry and gas chromatography/mass spectrometry. http://www.marketsandmarkets.com/Market-Reports/therapeutic-drug-monitoring-market-155350443.html

  8. On the basis of class of drug, the therapeutic drug monitoring market is segmented into antiepileptics, antibiotics, immunosuppressants, antiarrhythmic drugs, bronchodilators, psychoactive drugs, and others. By end user, the therapeutic drug monitoring market is segmented into hospital labs, commercial/private labs, and other end users. http://www.marketsandmarkets.com/Market-Reports/therapeutic-drug-monitoring-market-155350443.html

  9. North America is expected to account for more than half the therapeutic drug monitoring market share in 2015. It is the prime market for therapeutic drug monitoring due to the high awareness and acceptance of the benefits of therapeutic drug monitoring and growing healthcare expenditure. The market in Europe on the other hand is growing at a slower rate as the healthcare sector is recovering from the economic downturn and healthcare facilities are trying to minimize healthcare delivery costs. Growth in the APAC therapeutic drug monitoring market is comparatively slower due to dearth of skilled healthcare personnel performing therapeutic drug monitoring tests with minimal errors. http://www.marketsandmarkets.com/Market-Reports/therapeutic-drug-monitoring-market-155350443.html

  10. Major players in the therapeutic drug monitoring market include F. Hoffmann-La Roche AG (Switzerland), Siemens Healthcare (Germany), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), and Danaher Corporation (U.S.). http://www.marketsandmarkets.com/Market-Reports/therapeutic-drug-monitoring-market-155350443.html

  11. Contact Us Contact: Mr. Rohan Markets and Markets UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India 1-888-600-6441 Email: sales@marketsandmarkets.com http://www.linkedin.com/company/marketsandmarkets http://www.marketsandmarkets.com/Market-Reports/therapeutic-drug-monitoring-market-155350443.html

  12. About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. http://www.marketsandmarkets.com/Market-Reports/therapeutic-drug-monitoring-market-155350443.html

More Related